Kodiak Sciences
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Mid-pack momentum — held if you own it, not a fresh buy.
- Signal has read HOLD for 3 days.
- Recent price momentum is +270.0% on average (3-month/1-year).
- Main-fund capital flow has been a net inflow over the last 45 sessions.
- Short interest has fallen to 12.9% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-21 20:27 UTC
Data coverage: 4 of 6 factors. Missing data is not a zero score.
The radar needs all six factors. Available grades are shown below.
Valuation N/A
How expensive the stock is versus earnings, sales and its own 5-year history.
Not enough data to grade this factor.
Growth N/A
How fast revenue, profit and free cash flow are compounding.
Not enough data to grade this factor.
Profitability F
How much profit the business keeps from each dollar of sales and capital.
| Return on equity | -149.5% | Better than 4% |
| Return on invested capital | -107.3% | Better than 2% |
Momentum A+
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | 153.5% | Better than 100% |
| 6-month return | 168.2% | Better than 100% |
| 12-month return (ex latest month) | 313.0% | Better than 100% |
| Distance below 52-week high | 13.8% | Better than 75% |
Financial Health C+
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 4.7x | Better than 85% |
| Debt to assets | 16.8% | Better than 60% |
| Interest coverage | -20,036.8x | Better than 0% |
Analyst View B
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 85.7% | Better than 67% |
| Upside to average target | 30.9% | Better than 50% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 97.90
- Open
- 97.00
- Day range
- 96.53 - 100.89
- Avg price
- 97.70
- Volume
- 693.12K
- Turnover
- 67.72M
- Turnover ratei
- 1.77%
- Volume ratioi
- 0.86
- Amplitudei
- 4.46%
- 52-week rangei
- 20.38 - 112.79
Valuation
- P/Ei
- -22.49
- P/E (TTM)i
- -23.82
- P/Bi
- 506.09
- EPSi
- -4.32
- Book value / shi
- 0.19
- Net profit
- -282.51M
- Net assets
- 12.56M
Share structure
- Market cap
- 6.35B
- Float capi
- 3.82B
- Shares out
- 65.40M
- Float sharesi
- 39.27M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2018-10-04
13.8% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
+44.60M net over the window
Short interest
- Shares short
- 8.12M
- % of floati
- 12.91%
- Days to coveri
- 9.34
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Kodiak Sciences (KOD)?
Kodiak Sciences last traded at 97.17. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Kodiak Sciences's market cap?
About 6.35B.
What is the P/E ratio of Kodiak Sciences?
The trailing twelve-month P/E is -23.82. The Valuation tab shows it against the stock's own five-year range.
Does Kodiak Sciences pay a dividend?
Kodiak Sciences does not currently pay a regular dividend.
Is Kodiak Sciences a buy according to analysts?
The consensus of 7 analysts is a Buy rating, with an average 12-month price target of 127.20, which implies 30.9% upside from the current price. This is not investment advice.
What is Kodiak Sciences's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Kodiak Sciences a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.
Quote time 2026-11-20 19:57:11 · For reference only, not investment advice and not tailored to your situation.
Kodiak Sciences discussion 0 comments